Ingevity (NGVT) Cost of Revenue (2015 - 2026)

Ingevity (NGVT) has reported Cost of Revenue for 12 consecutive years, with $175.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cost of Revenue fell 14.04% year-over-year to $175.1 million; the TTM figure through Jun 2026 stood at $683.2 million (down 3.13% YoY), while the FY2025 annual figure was $706.1 million, down 3.97% from the prior year.
• Cost of Revenue climbed to $175.1 million in Q2 2026 per NGVT's latest filing, from $141.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $328.8 million in Q2 2023 and bottomed at -$137.5 million in Q4 2023.
• Historically, Cost of Revenue has averaged $209.2 million across 5 years, with a median of $222.0 million in 2024.
• Annual changes were most pronounced in 2023 — Cost of Revenue tumbled 149.42% — and 2024, when it surged 218.84%.
• Ingevity's Cost of Revenue stood at $278.2 million in 2022, then sank by 149.42% to -$137.5 million in 2023, then soared by 218.84% to $163.4 million in 2024, then increased by 2.39% to $167.3 million in 2025, then grew by 4.66% to $175.1 million in 2026.
• Business Quant data shows NGVT's Cost of Revenue at $175.1 million in Q2 2026, $141.6 million in Q1 2026, and $167.3 million in Q4 2025.